drugset / Trial / NCT00728780
Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Capsules Relative to That From Co-administration of ABT-335 and Rosuvastatin for the 5/45mg Dosage Form.
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to compare the pharmacokinetics of ABT-335 and rosuvastatin from ABT-143 relative to that from the co-administration of ABT-335 and rosuvastatin.
Timeline
- Start
- 2008-08
- Primary completion
- 2008-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ABT-335 | Small molecule | 135 mg | — |
| Comparator | Rosuvastatin | Small molecule | 15 mg | — |
Indications
No indication recorded.